Royalty Pharma is a financial services firm that invests and manages businesses in the biopharmaceutical industry.
Read moreAnnual Revenue
$2.3B
Royalty Pharma's revenue is the ranked 1st among it's top 10 competitors. The top 10 competitors average 299.3M. Over the last four quarters, Royalty Pharma's revenue has grown by 1.3%. Specifically, in Q1 2022's revenue was $562M; in Q4 2021, it was $575.7M; in Q3 2021, it was $585.8M; in Q2 2021, Royalty Pharma's revenue was $555M.